Lymphovenous Canada: Discussion pointSome lymphatic massage therapists have a policy of not providing therapy to individuals with active or terminal cancer, believing that such therapy might promote the spread of cancer through the lymphatic system. As a result, consumers with lymphedema - sometimes in great pain and distress - report having to go to several therapists before finding a therapist who is willing to assist them. Similar cautions are also cited by some therapists for the use of extremity pumps.
There appears to be no concrete scientific evidence, however, which suggests massage therapy promotes the spread of cancer. Many studies seem to indicate that massage therapy can potentially enhance the health, sense of well-being and quality of life of individuals with cancer.
Two recent studies have found no ill effects from the use of manual lymph drainage on cancer patients:
A 2010 U.S. National Institute of Cancer PDQ on lymphedema, notes that massage if done correctly should not cause any medical problems, however cautions that it should not be undertaken under the following circumstances:
In Diagnosis and therapy of malignant lymphedema, Fortschr Med 1998 Apr 30; 116(12):28-30, 32, 34 K. Ruger of the Fachklinik fur Lymphologie und Odemkrankheiten, St. Blasien, reports,
"With the standard physical treatment of edema...successful clinical management of malignant lymphedema is also possible. The sole contraindication of manual lymph drainage, we believe, locoregional tumor reoccurance, which can be completely eliminated by the immediate initiation of radical tumor treatment. The tumor reoccurance is the result not of falsely indicated manual lymph drainage, but of inadequate primary treatment that leaves behind residual tumor tissue, the early detection of which still remains an unresolved problem. Manual lymph drainage is indispensable for improving the quality of life of tumor patients with lymphedema."
In a retrospective study of 191 patients treated for head and neck cancer on the occurrence of lymphedema and therapy with manual lymph drainage, Preisler VK, Hage R, and Hoppe F report in Indications and risks of manual lymph drainage in head-neck tumors, Laryngorhinootologie, 1998 Apr; 77(4):207-12:
"100 patients had received lymphatic drainage, whereas 91 patients belonged to the group without lymphatic drainage therapy. In 37 cases a tumor reoccurance or local metastases were reported, 18 of whom had received lymphatic drainage and 19 belonged to the control group. Among these 37 patients neither the group with lymphatic drainage nor the control group differed significantly concerning stage of cancer, histopathological grading, the in sano/non in sano resection of the primary tumor and a lymphangiosis carcinomatosa.
Conclusion: A lymphatic drainage therapy for patients presenting with lymphedema after the oncological therapy does not increase the rate of local recurrencies. Moreover it improves the quality of life after the cancer therapy. As only few data are available for cases with non in sano surgery and tumors with lymphangiosis carcinomatosa, these cases should be excluded from lymphatic drainage therapy. A spreading of occult tumor cells in these patients might be possible."
Relief of anxiety and other physical symptoms associated with cancer or HIV/AIDS-related illnesses is well-documented:
Health care professionals have also reported to us that therapeutic ultrasound over a site of possible metastasis is contra-indicated because it's been shown to enhance tumour growth in lab mice.
Your comments and thoughts on this important topic are appreciated. Please contact us at info@lymphovenous-canada.com with your views.
Copyright © 1996-2012 Lymphovenous Canada.
Please do not reproduce material from this site without permission.
If you have any comments, you can contact us at
info@lymphovenous-canada.ca.
Last revised Jan. 6, 2011.